Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-25-026611
Filing Date
2025-07-21
Accepted
2025-07-21 16:05:39
Documents
26
Period of Report
2025-08-07

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20044912x2_def14a.htm   iXBRL DEF 14A 1082548
4 GRAPHIC logo_plustherapeutics.jpg GRAPHIC 33525
5 GRAPHIC logo_plustherapeuticsx1.jpg GRAPHIC 42581
6 GRAPHIC sig_marchedrick.jpg GRAPHIC 21627
7 GRAPHIC sig_marchedrickx1.jpg GRAPHIC 28584
8 GRAPHIC ny20044912x2_chair.jpg GRAPHIC 4707
9 GRAPHIC ny20044912x2_expert.jpg GRAPHIC 4309
10 GRAPHIC ny20044912x2_member.jpg GRAPHIC 4238
11 GRAPHIC ny20044912x2_pc01.jpg GRAPHIC 729334
12 GRAPHIC ny20044912x2_pc02.jpg GRAPHIC 671037
13 GRAPHIC ny20044912x2_pvpchart01.jpg GRAPHIC 160752
14 GRAPHIC ny20044912x2_pvpchart02.jpg GRAPHIC 185777
  Complete submission text file 0001140361-25-026611.txt   6719420

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION - LABEL LINKBASE pstv-20250807_lab.xml EX-101.LAB 2755
3 INLINE XBRL TAXONOMY EXTENSION - SCHEMA pstv-20250807.xsd EX-101.SCH 2927
29 EXTRACTED XBRL INSTANCE DOCUMENT ny20044912x2_def14a_htm.xml XML 179370
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Filer) CIK: 0001095981 (see all company filings)

EIN.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34375 | Film No.: 251137322
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)